Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
2500 participants
OBSERVATIONAL
2023-02-20
2029-02-19
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Epidemiologic, Laboratory, and Clinical Characterization of Individuals With Ocular Diseases
NCT00249392
Biomarkers of Common Eye Diseases
NCT04101604
Research on a New Intelligent Mobile Screening and Diagnosis Pattern for Ocular Diseases
NCT07003165
China Red Eye Study
NCT03814863
Study of Dark Adaptation in Age-Related Macular Degeneration
NCT01352975
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Be able to undergo yearly examinations for ≥5 years;
3. Age is older than 60 years;
4. Best-corrected visual acuity of both eyes is better than 20/32;
5. Intraocular pressure (non-contact tonometer) is between 10-21 mmHg;
6. Except for mild cataracts, no other structural abnormalities of the eye are found.
7. have fundus photographs of adequate quality as assessed with a standardized protocol by the University of Wisconsin Fundus Photograph Reading Center.
Exclusion Criteria
2. previous retinal or other ocular surgical procedures (other than cataract extraction and capsulotomy);
3. a chronic requirement for any systemic or ocular medication administered for other diseases and known to be toxic to the retina or optic nerve;
4. cataract surgery within three months or capsulotomy within six weeks before the qualification visit;
5. any systemic disease with a poor 5-year survival prognosis.
60 Years
95 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Zhongshan Ophthalmic Center, Sun Yat-sen University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Haotian Lin
The Vice President of Zhongshan Ophthalmic Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Zhongshan Ophthalmic Center, Sun Yat-sen University
Guangzhou, Guangdong, China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2023KYPJ003
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.